Answers are grounded in this paper and cite their sources.
Anaphylaxis to CoronaVac, an inactivated vaccine against COVID-19, is extremely rare. We report 12 cases of anaphylaxis after CoronaVac administration, focusing on clinical characteristics and management outcomes. Skin test and graded vaccine challenge were successfully performed in our cases and might be considered if an inactivated vaccine is the only remaining option.
No takes yet. Share an insight, caveat, or question.
Laisuan et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: